Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.29
-0.17 (-1.18%)
At close: Dec 2, 2025, 4:00 PM EST
14.29
0.00 (0.00%)
After-hours: Dec 2, 2025, 7:00 PM EST
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Takeda Pharmaceutical in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Takeda Pharmaceutical.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +39.96% | May 16, 2023 |
| TD Cowen | TD Cowen | Buy Maintains $24 → $30 | Buy | Maintains | $24 → $30 | +109.94% | Apr 4, 2023 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $20 | Hold → Strong Buy | Upgrades | $20 | +39.96% | Mar 16, 2023 |
| Cowen & Co. | Cowen & Co. | Hold → Buy Upgrades $21 → $24 | Hold → Buy | Upgrades | $21 → $24 | +67.95% | Jul 19, 2022 |
| Cowen & Co. | Cowen & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +36.46% | Nov 1, 2019 |
Financial Forecast
Revenue This Year
4.58T
from 4.58T
Increased by 0.01%
Revenue Next Year
4.60T
from 4.58T
Increased by 0.49%
EPS This Year
145.19
from 67.23
Increased by 115.96%
EPS Next Year
219.71
from 145.19
Increased by 51.32%
Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.9T | 5.0T | |
| Avg | 4.6T | 4.6T | |
| Low | 4.3T | 4.2T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.2% | 8.5% | |
| Avg | 0.0% | 0.5% | |
| Low | -6.9% | -7.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 205.28 | 464.08 | |
| Avg | 145.19 | 219.71 | |
| Low | 101.14 | 146.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 205.3% | 219.6% | |
| Avg | 116.0% | 51.3% | |
| Low | 50.4% | 0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.